tirzepatide glp-1 gip The dual agonist action of on various organs. GLP-1: Compound Tirzepatide

Tirzepatides are a class of Glucagon-like Peptide-1 receptor agonists and is one of the GLP-1/GIP medications that are used for Diabetes and Weight Loss

As doses approach 1.0 to 2.0 mg, most people begin seeing gradual weight loss

Keeping a log of heart rate measurements along with any associated symptoms can provide valuable information for healthcare providers when assessing the medication's cardiovascular effects and determining whether any intervention is needed

Together, these dual mechanisms create a compound effect that is significantly stronger than single-hormone GLP-1 medications

The incidence is approximately 0.4% at doses up to 450mg daily, which sounds small until you realize that certain conditions dramatically increase this baseline risk